• Expanding Journal Publishing Opportunities for Retina Specialists

    Ophthalmology Retina
    Highlights from the inaugural issue include “Evolution of Geographic Atrophy in Participants Treated With Ranibizumab for Neovascular Age-Related Macular Degeneration,” by Emily Y. Chew, MD, and “Laser Photocoagulation for Peripheral Retinal Capillary Hemangioblastoma in von Hippel-Lindau Disease,” by Alain Gaudric, MD.

    In response to the growing volume and quality of retina research, the Academy announced a new scientific journal for 2017—Ophthalmology® Retina. With the increased exposure to retina-specific manuscripts, ophthalmologists will be better able to stay on top of the latest advances in medical drug treatment, surgery, technology and science.

    This new print and online publication extends Ophthalmology®, one of the most-read clinical publications in the medical specialty. Ophthalmology has an impact factor of 6.75—the highest among clinical journals in the field. Ophthalmology Retina will benefit from the same experienced staff, editorial board and expedient review and publication process. The journal will publish bimonthly in 2017 and monthly starting in 2018.

    Ophthalmology receives and publishes more manuscripts on retina-related topics than any other subspecialty,” said George B. Bartley, MD, editor-in-chief of Ophthalmology. “In recent years, the retina subspecialty has made astonishing advances in medical drug treatment, surgery, technology and science. It was clear that we needed to provide retina researchers with more opportunities to get these exciting studies published as soon as possible.”

    The Academy appointed Andrew P. Schachat, MD, as editor-in-chief for the new publication. Dr. Schachat previously served as Ophthalmology’s editor-in-chief from 2003 to 2012. Since concluding his tenure, he has continued to serve as a senior editor for the publication, overseeing retina-related manuscripts.

    The new publication debuted with the January/February 2017 issue.